News
The rise of GLP-1 drugs is a reminder that we must move beyond the simple equation of thinness as health and value. These ...
A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists ...
22h
Parade on MSNRHONJ's Dolores Catania Opens Up About Her GLP-1All About Sarah Jessica Parker’s Son James and Twins Tabitha and Marion (Who Didn’t Know She Was Famous) Leavitt Gets ...
Explore "The Ozempic Revolution" by Dr Alexandra Sowa—a guide to weight-loss drugs like Ozempic, their benefits, side effects ...
Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.
People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...
2h
Futurism on MSNDoctors Say Ozempic Is Wildly Effective at Helping Addicts Beat CravingsWith their lengthening laundry list of health benefits, drugs like Ozempic and Wegovy are showing promise outside of weight ...
GLP-1RA users had a 37% lower risk of developing dementia compared to those on other antidiabetic drugs. Stroke risk reduced ...
Eli Lilly and Company (NYSE:LLY) is one of the high-margin pharma stocks to buy now. Eli Lilly and Company (NYSE:LLY) is set ...
Modern weight loss medications represent a breakthrough, but they are most effective when combined with the right lifestyle strategies. Here's what that looks like.
Madison Malone, SunStop food and brand manager, says traditional healthy offerings have declined in sales—and the c-store ...
Omada Health (OMDA) is a strong buy. Backed by 29 studies, key partnerships with Cigna and CVS drive growth, credibility, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results